PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Des (1-3) IGF-I 191 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.54
Des (1-3) IGF-I 191 Target Target bFGF 9,327 2 0.00 -0.99 0.01 0.61
Des (1-3) IGF-I 191 Target Disease Breast Cancer 173,695 7 0.00 -0.98 0.04 0.57
Des (1-3) IGF-I 191 Target Disease Diabetic Retinopathy 14,494 1 0.00 -1.00 0.01 0.58
Des (1-3) IGF-I 191 Target Disease Dementia 66,782 1 0.00 -1.00 0.01 0.54
Des (1-3) IGF-I 191 Target Target EGF 27,487 7 0.00 -0.98 0.04 0.61
CD14 9,941 Target Disease Genital Herpes 2,660 1 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Erythema 22,182 10 0.00 -1.00 0.00 0.54
CD14 9,941 Target Disease Asthma 109,610 180 0.01 -0.99 0.02 0.59
CD14 9,941 Target Disease Bacterial Infections 14,248 75 0.01 -0.99 0.01 0.64
CD14 9,941 Target Disease Nephrotic Syndrome 14,681 7 0.00 -1.00 0.00 0.55
CD14 9,941 Target Disease Ankylosing Spondylitis 9,665 11 0.00 -1.00 0.00 0.58
CD14 9,941 Target Target CD34 24,598 970 0.06 -0.93 0.10 0.74
CD14 9,941 Target Disease Lung Cancer 91,416 41 0.00 -1.00 0.00 0.54
CD14 9,941 Target Target BRAF 4,766 2 0.00 -1.00 0.00 0.54
CD14 9,941 Target Target BDNF 11,163 4 0.00 -1.00 0.00 0.54
CD14 9,941 Target Target Complement Component C1q 167 1 0.00 -1.00 0.01 0.59
CD14 9,941 Target Disease Proteinuria 28,803 13 0.00 -1.00 0.00 0.54
CD14 9,941 Target Disease Hyperlipidemia 15,317 5 0.00 -1.00 0.00 0.53
CD14 9,941 Target Target Elastase 13,875 32 0.00 -1.00 0.00 0.60
CD14 9,941 Target Target Hypoxia-Inducible Factor 1-Alpha 923 1 0.00 -1.00 0.00 0.56
CD14 9,941 Target Disease Muscle Weakness 9,178 1 0.00 -1.00 0.00 0.50
CD14 9,941 Target Disease Down Syndrome 10,290 3 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Chronic Alcoholism 3,068 2 0.00 -1.00 0.00 0.55
CD14 9,941 Target Target AXL 633 2 0.00 -1.00 0.00 0.58
CD14 9,941 Target Disease Brain Tumors 16,749 3 0.00 -1.00 0.00 0.52
CD14 9,941 Target Disease Sinusitis 12,330 1 0.00 -1.00 0.00 0.49
CD14 9,941 Target Disease Iron Deficiency Anemia 5,021 1 0.00 -1.00 0.00 0.52
CD14 9,941 Target Target Macrophage Metalloelastase 100 1 0.00 -0.99 0.01 0.60
CD14 9,941 Target Target APO-2L 90 2 0.00 -0.99 0.02 0.62
CD14 9,941 Target Target CCL21 808 6 0.00 -1.00 0.01 0.61
CD14 9,941 Target Disease Inflammation 252,734 1,209 0.02 -0.93 0.12 0.63
CD14 9,941 Target Disease Vertigo 10,084 1 0.00 -1.00 0.00 0.50
CD14 9,941 Target Target CXCL2 750 14 0.01 -0.99 0.02 0.64
CD14 9,941 Target Target CCL1 220 4 0.00 -0.99 0.02 0.62
CD14 9,941 Target Disease Heart Disease 118,291 36 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Liver Disease 49,817 82 0.00 -1.00 0.01 0.59
CD14 9,941 Target Drug Doxorubicin 28,033 14 0.00 -1.00 0.00 0.55
CD14 9,941 Target Target Galectin-1 1,131 5 0.00 -1.00 0.00 0.60
CD14 9,941 Target Target Activin A 2,048 8 0.00 -1.00 0.00 0.60
CD14 9,941 Target Disease Septic Arthritis 4,121 1 0.00 -1.00 0.00 0.52
CD14 9,941 Target Target BMP-2 3,889 9 0.00 -1.00 0.00 0.59
CD14 9,941 Target Target CCL8 197 5 0.00 -0.99 0.03 0.63
CD14 9,941 Target Target Pancreatic Alpha-Amylase 423 1 0.00 -1.00 0.00 0.57
CD14 9,941 Target Target CXCL10 2,386 39 0.01 -0.99 0.02 0.66
CD14 9,941 Target Drug Doxycycline 9,324 2 0.00 -1.00 0.00 0.52
CD14 9,941 Target Disease Ulcers 45,142 12 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Hyperlipoproteinemia 2,954 1 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Inflammatory Bowel Diseases 4,684 17 0.00 -1.00 0.00 0.61
CD14 9,941 Target Target Glutathione Peroxidase 3 132 2 0.00 -0.99 0.02 0.61